Related Experiment Videos
Scoring of chronic hepatitis.
Peter J Scheuer1, Richard A Standish, Amar P Dhillon
1Department of Histopathology, Royal Free Hospital, Pond Street, London NW3 2QG, UK. scheuer@scheupj.demon.co.uk
Clinics in Liver Disease
|July 19, 2002
Summary
Assessing chronic hepatitis severity and its structural damage is crucial for research and clinical trials. While subjective grading and staging methods exist, morphometry of fibrous tissue presents an objective alternative for biopsy assessment.
Area of Science:
- Hepatology
- Pathology
- Medical Research
Background:
- Chronic hepatitis assessment relies on grading severity and staging structural damage.
- Current methods are used in clinical trials and research.
- Subjectivity in grading and staging leads to observer variation.
Purpose of the Study:
- To discuss the methods for grading chronic hepatitis severity and staging its consequences.
- To highlight the limitations of subjective assessment methods.
- To introduce morphometry of fibrous tissue as an alternative approach.
Main Methods:
- Review of existing grading and staging methods for chronic hepatitis.
- Discussion of intra- and interobserver variation.
- Introduction of morphometry of fibrous tissue for biopsy assessment.
Main Results:
- Grading and staging are subjective, leading to inherent observer variation.
- Categorical data from grading/staging require specific analytical treatment.
- Morphometry offers a quantitative approach to biopsy assessment.
Conclusions:
- Subjective grading and staging of chronic hepatitis, while common, have limitations due to observer variability.
- Morphometry of fibrous tissue provides a potentially more objective method for assessing liver biopsy samples.
- Further research may explore the utility of morphometry in clinical settings and trials.